Comorbidities in Patients with Type 2 Diabetes Mellitus: a Report on 219 Cases

被引:0
作者
Gaman, Mihnea-Alexandru [1 ]
Dobrica, Elena-Codruta [1 ]
Cozma, Matei Alexandru [1 ]
Gaman, Amelia Maria [2 ,3 ]
Marcu, Dragos [4 ]
Stanescu, Ana Maria Alexandra [1 ]
Iancu, Mihaela Adela [1 ]
Dediu, Giorgiana Nicoleta [1 ]
Diaconu, Camelia Cristina [1 ,5 ]
机构
[1] Carol Davila Univ Med & Pharm, Fac Med, Bucharest, Romania
[2] Univ Med & Pharm Craiova, Dept Pathophysiol, Craiova, Romania
[3] Filantropia City Hosp, Dept Hematol, Craiova, Romania
[4] Univ Emergency Cent Mil Hosp Dr Carol Davila, Clin Urol, Bucharest, Romania
[5] Clin Emergency Hosp Bucharest, Internal Med Clin, Bucharest, Romania
来源
PROCEEDINGS OF THE 35TH BALKAN MEDICAL WEEK | 2018年
关键词
diabetes mellitus; comorbidity; arterial hypertension; disease burden; PREVALENCE; HYPERTENSION;
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Introduction A great number of comorbidities is often registered in patients with type 2 diabetes mellitus (T2DM), increasing the costs associated with the management of this disease. Our objective is to describe the characteristics and comorbidities of a study group of 219 T2DM patients. Methods 219 T2DM patients were selected to partake in this study (mean age = 69.04 +/- 10.79 years, range 37-93, 51.14% female). Patients were identified by a database search of diagnostic codes of all discharge diagnoses and medical data were retrieved from the Clinical Emergency Hospital of Bucharest records. Results The following comorbidities were registered: 80.82% arterial hypertension, 47.95% dyslipidemia, 45.21% valvulopathy, 36.07% heart failure, 33.79% arrhythmia, 33.33% obesity, 32.88% chronic kidney disease, 16.44% anemia, 12.79% hepatic steatosis, 10.50% diabetic nephropathy, 9.59% peripheral arterial disease, 8.68% diabetic neuropathy, 8.67% chronic venous insufficiency, 7.77% dyselectrolytemia and 4.57% diabetic retinopathy. Conclusions Our study clearly reinforces the need for a therapeutic approach centered not only on T2DM alone, but also on the T2DM-related and non-related comorbidities that increase the disease burden in diabetic patients and also the health-associated costs of this disease.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 28 条
  • [1] Berceanu D., 2016, ARCH BALK MED UNION, V51, P506
  • [2] Cirpaciu D., 2017, ARCH BALK MED UNION, V52, P439
  • [3] Dediu G, 2017, ARCH BALK MED UNION, V52, P430
  • [4] DOES THE PRESENCE OF ARTERIAL HYPERTENSION INFLUENCE THE PRESCRIPTION OF ANTIPLATELET DRUGS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS?
    Diaconu, C.
    Gaman, M.
    Dobrica, E.
    Cozma, M.
    Dediu, G.
    Gaman, A.
    Arsene, A.
    Dragoi, C.
    Nicolae, A.
    Velescu, B.
    Paraschiv, B.
    Tincu, R.
    Iancu, M.
    [J]. JOURNAL OF HYPERTENSION, 2018, 36 : E277 - E278
  • [5] AN AGE-RELATED COMPARISON BETWEEN COMORBIDITIES AND TREATMENT OF HYPERTENSIVE PATIENTS
    Diaconu, C.
    Istratie, B.
    Nastasa, A.
    Zaki, A.
    Balaceanu, L.
    Iancu, M.
    [J]. JOURNAL OF HYPERTENSION, 2016, 34 : E321 - E321
  • [6] A COMPARATIVE ANALYSIS OF THE HYPERTENSION TREATMENT DEPENDING ON COMORBIDITIES: INSIGHTS FROM CLINICAL PRACTICE
    Diaconu, C.
    Nastasa, A.
    Zaki, A.
    Istratie, B.
    Nazari, R.
    Iancu, M.
    Balaceanu, L.
    [J]. JOURNAL OF HYPERTENSION, 2016, 34 : E320 - E321
  • [7] DIACONU C, 2018, J HYPERTENS S1, V36, pE27
  • [8] PREVALENCE OF HYPOXIC HEPATITIS IN HEART FAILURE PATIENTS
    Diaconu, C. C.
    Balaceanu, A. L.
    Costache, C.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S515 - S515
  • [9] Diaconu C, 2017, INT C INTERD MANAG D, P170
  • [10] Diaconu C, 2016, INT C INTERD MANAG D, P201